First ‘cell rejuvenation’ therapy in humans: Can ageing finally be treated?
•The innovative cell rejuvenation therapy, known as ER-100, is set to enter human trials, focused on enhancing the functionality of aging cells rather than attempting to reverse the aging process.
•This revolutionary approach shows promise in potentially decelerating age-related decline and addressing conditions like Alzheimer's.
•However, medical professionals advise caution due to ongoing research into long-term safety and efficacy, indicating a shift in understanding aging as a fixed outcome.
هذا الخبر من Times of India. خبر يقدم أدوات ذكاء اصطناعي للتلخيص والترجمة والاستماع.
The innovative cell rejuvenation therapy, known as ER-100, is set to enter human trials, focused on enhancing the functionality of aging cells rather than attempting to reverse the aging process. This revolutionary approach shows promise in potentially decelerating age-related decline and addressing conditions like Alzheimer's. However, medical professionals advise caution due to ongoing research into long-term safety and efficacy, indicating a shift in understanding aging as a fixed outcome.المصدر: Times of India | Source: Times of India
ملاحظة تحريرية | Editorial Note: نُشر هذا المقال في الأصل بواسطة Times of India. خبر (Khabr) هي منصة إعلامية أردنية مرخّصة تعمل بالذكاء الاصطناعي. نضيف قيمة تحريرية من خلال: تحليل ذكي للأخبار، ملخصات تلقائية، رواية صوتية بالذكاء الاصطناعي، ترجمة متعددة اللغات، وتدقيق الحقائق. هدفنا جعل الأخبار أكثر وضوحاً وسهولةً للقارئ العربي.
This article was originally published by Times of India. Khabr is a licensed Jordanian AI-powered news platform (Registration #82086). We add editorial value through: AI-powered news analysis, automated summaries, AI audio narration, multi-language translation (Arabic, English, French, Turkish), and AI fact-checking. Our mission is to make news more accessible and understandable for Arabic-speaking audiences worldwide.
